Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, the Financial Times reported on Monday, citing people familiar with the matter.

Type 1 diabetes (T1D) is an autoimmune condition where the immune system destroys insulin-producing β-cells in the pancreas.

Your brain makes insulin—the same insulin produced by your pancreas. The same insulin that is not produced in people with ...

A study by Bedi and others at the School of Planning and Architecture, Bhopal, identified Bengaluru, Kolkata, Hyderabad, ...